← Back to Search

Immunosuppressant

Arm A Cyclosporine for SARS

Phase 2
Waitlist Available
Research Sponsored by Bryan Burt, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 14
Awards & highlights

Study Summary

This trial will test if an oral formulation of cyclosporine can help treat COVID-19.

Eligible Conditions
  • SARS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
WHO(World Health Organization) COVID-19 Clinical Severity Scale

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm B Standard of CareExperimental Treatment1 Intervention
Standard of Care Treatment, N= 25 Patients 7 days
Group II: Arm A CyclosporineExperimental Treatment1 Intervention
Neoral, N=50 Patients 2.5 mg/kg PO BID 7 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cyclosporine
FDA approved

Find a Location

Who is running the clinical trial?

Bryan Burt, MDLead Sponsor
Brigham and Women's HospitalOTHER
1,609 Previous Clinical Trials
11,470,280 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is Arm A Cyclosporine often recommended?

"Arm A Cyclosporine is a medication that is frequently used to treat patients post-transplant. It can also be effective in treating conditions such as lupus nephritis, bulla, and excessive tearing."

Answered by AI

Are there other ongoing research projects that use Arm A Cyclosporine?

"There are 71 active clinical trials worldwide that are studying Arm A Cyclosporine. Out of those, 13 studies are in Phase 3. While a few Assiut-based sites are finishing up their research, there are 475 other locations running trials for Arm A Cyclosporine."

Answered by AI

Is Arm A Cyclosporine a safe medication for patients to take?

"While Arm A Cyclosporine has not yet been proven effective, it did receive a score of 2 because there is some clinical data supporting its safety."

Answered by AI

What is the total number of participants in this trial?

"That is correct, the online information from clinicaltrials.gov reveals that this study is still currently enrolling patients. The trial was originally advertised on November 23rd 2020 with the most recent update being October 26th 2021. They are looking for a total of 75 individuals across 1 location."

Answered by AI

If I qualify, who can sign up for this clinical study?

"Researchers are looking for 75 individuals, within the ages of 18 and 90 who have contracted covid-19. Furthermore, it is essential that these participants also meet the following clinical criteria: 3.1.2 Patients admitted to non-ICU hospital floors or in an emergency department awaiting admission to a non-ICU hospital bed., 3.1.3 WHO COVID Scale Score 4 (Oxygen by mask or nasal prongs or WHO COVID Scale Score 5 (non-invasive ventilation or high-flow oxygen)., 3.1.4 Age 18 to 90 years old., 3.1.5 ECOG ("

Answered by AI

Does age play a role in patients' ability to join this trial?

"As long as they are between 18-90 years old, patients satisfy the age criteria for this study."

Answered by AI

Is this study still enrolling participants?

"The study, which as of 10/26/2021 is still recruiting patients, was originally posted on 11/23/2020."

Answered by AI
~11 spots leftby Apr 2025